Elucidating the role of an immunomodulatory protein in cancer: From protein expression to functional characterization
Leepakshi Khurana1, Mei ElGindi2, Pathricia V Tilstam2
1Department of Pharmacology, School of Medicine, Yale University, New Haven, CT, United States.
Abstract:
Several fundamental discoveries made over the last two decades, in the field of cancer biology, have increased our understanding of the complex tumor micro- and macroenvironments. This has shifted the current empirical cancer therapies to more rationalized treatments targeting immunomodulatory proteins. From the point of identification, a protein target undergoes several interrogations, which are necessary to truly define its druggability. Here, we outline some basic steps that can be followed for in vitro characterization of a potential immunomodulatory protein target. We describe procedures for recombinant protein expression and purification including key annotations on protein cloning, expression systems, purification strategies and protein characterization using structural and biochemical approaches. For functional characterization, we provide detailed protocols for using flow-cytometric techniques in cell lines or primary cells to study protein expression profiles, proliferation, apoptosis and cell-cycle changes. This multilevel approach can provide valuable, in-depth understanding of any protein target with potential immunomodulatory effects.
Insights
This study details in vitro methods for characterizing potential immunomodulatory protein targets in cancer biology. It covers recombinant protein expression, purification, and functional assays for drug development.
Area of Science:
- Cancer Biology
- Immunology
- Drug Discovery
Background:
- Recent advances in cancer biology have improved understanding of tumor microenvironments.
- This has led to a shift towards targeted therapies focusing on immunomodulatory proteins.
Purpose of the Study:
- To outline essential in vitro characterization steps for potential immunomodulatory protein targets.
- To provide a framework for assessing protein druggability.
Main Methods:
- Recombinant protein expression and purification (cloning, expression systems, purification strategies).
- Protein characterization using structural and biochemical approaches.
- Functional characterization via flow cytometry for cell-based assays (expression, proliferation, apoptosis, cell cycle).
Main Results:
- Established protocols for comprehensive in vitro protein target evaluation.
- Demonstrated a multilevel approach for in-depth understanding of protein targets.
Conclusions:
- The described methods facilitate the rigorous characterization of immunomodulatory protein targets.
- This approach supports the development of rationalized cancer therapies.
Related Concept Videos
Tumor Immunotherapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...


